Daily Derm Times: April 7, 2025

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

Novel Injection Technique Prevents Sunken Cheek in Masseter Hypertrophy Treatment

The method was safe and effective with high patient satisfaction rates 4 weeks post-injection.

Shaping the Future of Dermatology With Insights From AAD 2025 and Beyond

Explore key takeaways from AAD 2025, rosacea insights, psoriasis updates, and expert interviews in the latest issue of Dermatology Times.

Study Reports Efficacy of Tofacinitib in Itch, Skin Infiltration Reduction for Prurigo Nodularis

Tofacitinib showed promise for easing itch and skin symptoms in prurigo nodularis, though effects may lessen over time.

Balancing Safety and Progress in Pediatric AD

Current JAK inhibitors are approved only for those 12 and older, leaving younger patients without access.

Large-Spot, Variable-Pulsed KTP Laser Demonstrates Safety and Efficacy in Port-Wine Birthmarks

Long-pulsed KTP laser showed promise as a safe, effective alternative to PDL for treating port-wine birthmarks over 3 years.

Bridging Medicine and Machine Learning

The guide prepares students to critically engage with AI tools and understand their real-world implications.

Allergic Contact Dermatitis Remains Prevalent, Negatively Impacts Quality of Life

Researchers conducted a comprehensive review of ACD, detailing the condition’s epidemiology, pathophysiology, clinical manifestations, diagnostic approaches, and therapeutic options.

Dupilumab Improves DLQI and IGA Scores in Hand and Facial Eczema in Patients With Moderate to Severe AD

Patients reported the face, neck, and inner arms as the most affected body regions before treatment.